EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PET/CT Radiomics Integrated with Clinical Indexes as a Tool to Predict Ki67 in Breast Cancer: a Pilot Study

Dawei Li, Hui Ding, Yuting Liao, Xiao Yu, Youmin Guo, Cong Shen iD

Nuclear Medicine and Molecular Imaging · 2025-06 · 59 (3) · 164-173

DOI: 10.1007/s13139-024-00896-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nuclear Medicine and Molecular Imaging, online erschienen am 29.11.2024. Verfasst von Dawei Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Positron Emission Tomography/Computer Tomography, The First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta West Road, Xi'a…. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science and Basic Research Project of Shaanxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aims to assess the value of radiomics features integrated with clinical characteristics for estimating Ki67 expression in patients with breast cancer (BC).

Methods

In total, 114 patients with BC performed 18 F-FDG PET/CT scans. Patients were randomly assigned to a training set ( n = 79, 55 cases of Ki67 + and 24 cases of Ki67-) and a validation set ( n = 35, 24 cases of Ki67 + and 11 cases of Ki67-). Thirteen clinical characteristics and 704 radiomics features were extracted, and 4 clinical and 8 radiomics features were selected. Three models were developed, including the clinical model, the radiomics model, and the combined model. Model performance was evaluated using the ROC curve, and clinical utility was assessed through decision curve analysis (DCA).

Results

The N stage, tumor morphology, SUVmax, and the longest diameter significantly differed between Ki67 + and Ki67- groups (all P < 0.05). Eight radiomics features were selected for the radiomics model. The area under the curve of the combined model in the training and test group was 0.90 (95% CI: 0.82∼0.97) and 0.81 (95% CI: 0.64∼0.99), respectively. The combined model significantly outperformed both the radiomics model and the clinical model alone ( P < 0.05). The DCA curve demonstrated the superior clinical utility of the combined model compared to the clinical model and radiomics model.

Conclusions

PET/CT image-based radiomics features combined with clinical features have the potential to predict Ki67 expression in BC.

Schlagwörter

Stichwörter der Autor:innen

Breast cancerKi67PET/CTPredictive modelRadiomics

Autor:innen und Institutionen

  • Department of Positron Emission Tomography/Computer Tomography, The First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta West Road, Xi'an, Shaanxi 710061 China.
  • Department of Radiology, The First People's Hospital of Jinzhou District, Dalian, Liaoning P.R. China.
  • Clinical & Technical Support, Philips Healthcare, Shanghai, China.

ORCID-Profile: Cong Shen

Förderung

  • Natural Science and Basic Research Project of Shaanxi Province

Zitieren

APA

Li, D., Ding, H., Liao, Y., Yu, X., Guo, Y., & Shen, C. (2025). PET/CT Radiomics Integrated with Clinical Indexes as a Tool to Predict Ki67 in Breast Cancer: a Pilot Study. Nuclear Medicine and Molecular Imaging, 59(3), 164-173. https://doi.org/10.1007/s13139-024-00896-9

Vancouver

Li D, Ding H, Liao Y, Yu X, Guo Y, Shen C. PET/CT Radiomics Integrated with Clinical Indexes as a Tool to Predict Ki67 in Breast Cancer: a Pilot Study. Nuclear Medicine and Molecular Imaging. 2025;59(3):164-173. doi:10.1007/s13139-024-00896-9

BibTeX
@article{Li2025,
  author = {Li, Dawei and Ding, Hui and Liao, Yuting and Yu, Xiao and Guo, Youmin and Shen, Cong},
  title = {PET/CT Radiomics Integrated with Clinical Indexes as a Tool to Predict Ki67 in Breast Cancer: a Pilot Study},
  journal = {Nuclear Medicine and Molecular Imaging},
  year = {2025},
  volume = {59},
  number = {3},
  pages = {164--173},
  doi = {10.1007/s13139-024-00896-9}
}
Kostenlos starten →